Avience Biomedicals Limited Financial Ratios
AVIENCE · Healthcare · Current price ₹273.9
P/E ratio
12.6x
P/B ratio
2.1x
ROE
27.9%
ROCE
23.2%
Debt / Equity
0.92
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 12.6x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 2.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 27.9% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 23.2% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.92 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Avience Biomedicals Limited's latest numbers.
Avience Biomedicals Limited profitability
Avience Biomedicals Limited generates a return on equity of 27.9% and a return on capital employed of 23.2%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.92 and a P/E of 12.6x, Avience Biomedicals Limited is moderately leveraged. Our overall business-quality score for the company is 5.8 / 10.
Understand the ratios
More on Avience Biomedicals Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.